Xtant Medical Holdings Inc (XTNT) — Capital Reinvestment Ratio

Latest as of December 2025: 0.07x

Xtant Medical Holdings Inc (XTNT) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.38 Million) in capital expenditures ($395.00K). Check Xtant Medical Holdings Inc (XTNT) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

$5.38 Million
USD

Capital Expenditures

$395.00K
USD

Data as of

Dec 2025
Most recent filing

Xtant Medical Holdings Inc Capital Reinvestment Ratio (2018–2025)

This chart tracks Xtant Medical Holdings Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Xtant Medical Holdings Inc.

Annual Capital Reinvestment Ratio for Xtant Medical Holdings Inc (2018–2025)

Year-by-year Capital Reinvestment Ratio for Xtant Medical Holdings Inc from 2018 to 2025. See XTNT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.19x $12.55 Million $2.38 Million ▼ -96.1%
2021 4.82x $439.00K $2.12 Million ▲ +835.8%
2018 0.51x $1.21 Million $624.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow